FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2975061402> ?p ?o ?g. }

• W2975061402 endingPage "214" @default.
• W2975061402 startingPage "199" @default.
• W2975061402 abstract "Alzheimer’s disease (AD) is a chronic neurodegenerative disorder characterized by progressive cognitive impairments. Vitegnoside is a flavonoid present in the medicinal plant Vitex negundo, widely used as a folk medicine in several Asian countries including China. It possesses several biological ac tivities, including axon outgrowth, but no evidence is available on its effect on AD. Since no effective treatment is available to cure AD, the effect of vitegnoside on this disease was investigated. The human neuroblastoma SH-SY5Y cell line carrying the Swedish mutation that induces AβPP overexpression was used as an in vitro AD cell model. AβPP overexpression does not induce toxicity per se unless triggered by copper. Vitegnoside promoted neuroprotection through the improvement of cell viability, maintenance of cytomembrane integrity and nuclear homogeneity in these cells, but these effects were not observed in the copper-treated SH-SY5Y cells without AβPP overexpression used as the wild-type control, indicating that vitegnoside exerted neuroprotection under copper-triggered Aβ toxic conditions. Vitegnoside failed to decrease AβPP expression, Aβ40/42 levels, and oxidative stress due to copper-induced Aβ toxicity. However, its administration protected the mitochondrial function and restored the imbalance between pro-apoptotic and anti-apoptotic proteins. Additionally, vitegnoside inactivated p38 MAPK/MK2, JNK/c-Jun, and downstream NF-κB inflammatory transductions. Furthermore, the inactivation of p38 MAPK/JNK signaling contributed to vitegnoside-mediated neuroprotection resulting from pharmacological inhibition of p38 MAPK/JNK and in silico interaction prediction. Our study revealed the neuroprotective effect of vitegnoside and its potential mechanisms against copper-induced Aβ neurotoxicity. These findings highlighted the potential therapeutic effect of vitegnoside against AD progression." @default.
• W2975061402 created "2019-10-03" @default.
• W2975061402 creator A5001179479 @default.
• W2975061402 creator A5003820242 @default.
• W2975061402 creator A5014298605 @default.
• W2975061402 creator A5019707913 @default.
• W2975061402 creator A5026928088 @default.
• W2975061402 creator A5066573930 @default.
• W2975061402 date "2019-10-29" @default.
• W2975061402 modified "2023-10-09" @default.
• W2975061402 title "Vitegnoside Mitigates Neuronal Injury, Mitochondrial Apoptosis, and Inflammation in an Alzheimer’s Disease Cell Model via the p38 MAPK/JNK Pathway" @default.
• W2975061402 cites W116732461 @default.
• W2975061402 cites W1786911182 @default.
• W2975061402 cites W1880679495 @default.
• W2975061402 cites W1922892619 @default.
• W2975061402 cites W1958434785 @default.
• W2975061402 cites W1968602836 @default.
• W2975061402 cites W1971607574 @default.
• W2975061402 cites W1985925844 @default.
• W2975061402 cites W1987133102 @default.
• W2975061402 cites W1987637427 @default.
• W2975061402 cites W1995335649 @default.
• W2975061402 cites W1996405087 @default.
• W2975061402 cites W2004427787 @default.
• W2975061402 cites W2017562477 @default.
• W2975061402 cites W2019968489 @default.
• W2975061402 cites W2021511409 @default.
• W2975061402 cites W2021654785 @default.
• W2975061402 cites W2022642951 @default.
• W2975061402 cites W2027328852 @default.
• W2975061402 cites W2034502915 @default.
• W2975061402 cites W2036556087 @default.
• W2975061402 cites W2046188137 @default.
• W2975061402 cites W2052987925 @default.
• W2975061402 cites W2057112578 @default.
• W2975061402 cites W2064572306 @default.
• W2975061402 cites W2066571367 @default.
• W2975061402 cites W2069293496 @default.
• W2975061402 cites W2078554455 @default.
• W2975061402 cites W2084633330 @default.
• W2975061402 cites W2087660290 @default.
• W2975061402 cites W2093112928 @default.
• W2975061402 cites W2093557429 @default.
• W2975061402 cites W2094948453 @default.
• W2975061402 cites W2128389187 @default.
• W2975061402 cites W2129526111 @default.
• W2975061402 cites W2131487701 @default.
• W2975061402 cites W2137437449 @default.
• W2975061402 cites W2146857824 @default.
• W2975061402 cites W2147290992 @default.
• W2975061402 cites W2163491445 @default.
• W2975061402 cites W2379046857 @default.
• W2975061402 cites W2398590379 @default.
• W2975061402 cites W2560096488 @default.
• W2975061402 cites W2611965998 @default.
• W2975061402 cites W2745990364 @default.
• W2975061402 cites W2752591195 @default.
• W2975061402 cites W2788808587 @default.
• W2975061402 cites W2798054687 @default.
• W2975061402 cites W2883810413 @default.
• W2975061402 cites W2950580030 @default.
• W2975061402 cites W2955880269 @default.
• W2975061402 doi "https://doi.org/10.3233/jad-190640" @default.
• W2975061402 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31561371" @default.
• W2975061402 hasPublicationYear "2019" @default.
• W2975061402 type Work @default.
• W2975061402 sameAs 2975061402 @default.
• W2975061402 citedByCount "18" @default.
• W2975061402 countsByYear W29750614022020 @default.
• W2975061402 countsByYear W29750614022021 @default.
• W2975061402 countsByYear W29750614022022 @default.
• W2975061402 countsByYear W29750614022023 @default.
• W2975061402 crossrefType "journal-article" @default.
• W2975061402 hasAuthorship W2975061402A5001179479 @default.
• W2975061402 hasAuthorship W2975061402A5003820242 @default.
• W2975061402 hasAuthorship W2975061402A5014298605 @default.
• W2975061402 hasAuthorship W2975061402A5019707913 @default.
• W2975061402 hasAuthorship W2975061402A5026928088 @default.
• W2975061402 hasAuthorship W2975061402A5066573930 @default.
• W2975061402 hasConcept C185592680 @default.
• W2975061402 hasConcept C190283241 @default.
• W2975061402 hasConcept C25498285 @default.
• W2975061402 hasConcept C2776151105 @default.
• W2975061402 hasConcept C2776715637 @default.
• W2975061402 hasConcept C2779083432 @default.
• W2975061402 hasConcept C31573885 @default.
• W2975061402 hasConcept C51551487 @default.
• W2975061402 hasConcept C53227056 @default.
• W2975061402 hasConcept C54355233 @default.
• W2975061402 hasConcept C55493867 @default.
• W2975061402 hasConcept C57074206 @default.
• W2975061402 hasConcept C62478195 @default.
• W2975061402 hasConcept C81885089 @default.
• W2975061402 hasConcept C86803240 @default.
• W2975061402 hasConcept C95444343 @default.
• W2975061402 hasConcept C98274493 @default.
• W2975061402 hasConceptScore W2975061402C185592680 @default.
• W2975061402 hasConceptScore W2975061402C190283241 @default.

• next